Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data.
BACKGROUND
Peripheral arterial disease (PAD) is caused by narrowing of the arteries in the lower extremities. Limited data exist concerning the impact of diffuse vascular disease (DVD) on prognosis and costs. Thus, the objective of this study is to estimate the impact of DVD on morbidity, mortality and costs.


METHODS
PAD was identified between 1985 and 1995 and classified by extent of DVD at diagnosis: none (PAD only, reference group), prior myocardial infarction (MI), prior stroke, prior MI and stroke (MI + stroke), prior transient ischemic attack (TIA). Deaths and hospitalizations were identified through December 2000. Hospitalization costs were estimated from the Ontario Case Cost Project, reported in 2002 $CAD. Proportional hazards analyses measured the impact of vascular involvement on mortality while controlling for risk factors (e.g., age, cardiovascular history).


RESULTS
Overall, 16,439 patients with PAD were included; 14.8% had a prior MI, 10.2% a prior stroke, 2.6% prior MI + stroke, 6.4% prior TIA, two-thirds had PAD only. Median survival was shorter for patients with prior MI (9.3 yrs), TIA (6.3), stroke (4.7), and MI+stroke (4.1) versus the reference group (9.9, p < 0.05, all comparisons). Analyses revealed that the death risk was 60% higher in patients with prior stroke and 84% higher for MI + stroke. Atherothrombotic and bleeding event-related costs were $712, $337, $268, and $170 higher per patient/year of follow-up in patients with a history of MI+stroke, MI, stroke, and TIA, respectively.


CONCLUSIONS
Patients diagnosed with PAD with DVD have higher risk of poor outcomes and increased costs.
Migliaccio-Walle
Kristen
K
United BioSource Corporation, Lexington, MA, USA.
Stokes
Michael
M
Proskorovsky
Irina
I
Popovici-Toma
Dan
D
El-Hadi
Wissam
W
D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D017048:Health Care Costs; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology* / Q000401:mortality; D058729:Peripheral Arterial Disease / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology* / Q000401:mortality; D011379:Prognosis; D012306:Risk; D012525:Saskatchewan; D020521:Stroke / Q000453:epidemiology*; D016896:Treatment Outcome
J Vasc Interv Radiol. 2002 Jan;13(1):7-11
11788688
Can J Cardiol. 2009 Jun;25(6):345-51
19536375
Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79
17296541
Am Heart J. 2006 May;151(5):1123-8
16644349
BMC Health Serv Res. 2006 Aug 14;6:99
16907982
Congest Heart Fail. 2007 Nov-Dec;13(6):319-22
18046089
J Manag Care Pharm. 2005 Nov-Dec;11(9):727-34
16300416
JAMA. 2001 Sep 19;286(11):1317-24
11560536
Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53
18402543
Am Heart J. 2003 Apr;145(4):622-7
12679757
Circulation. 2004 Aug 10;110(6):738-43
15262830
Circulation. 2006 Jan 24;113(3):388-93
16432070
Am Heart J. 2007 Jan;153(1):140-6
17174652